HIV Care

  • Creator
  • #17703 Reply

    The HVTN 505 approach to the changing HIV prevention landscape provided a lot of insight. We know the IPM Dapivirine Vaginal ring received positive opinion from EMA. What do you think if it were approved as a new HIV prevention tool for women during the PrEPVacc trial?


  • HIV Care

  • Sylvia Kusemererwa

    August 10, 2020 at 7:29 pm

    That would be interesting to observe! However, if provided as part of the study design, women would choose between taking a pill and using a ring. Similar to what is being done under the REACH trial, 6 months on pills and 6 months on the ring followed by a crossover.

Viewing 1 of 1 replies
Reply to: Vincent Basajja
Your information:

Original Post
0 of 0 posts June 2018